Virginie Helias leaves Procter & Gamble after 38 years, with Michele Baeten taking over global sustainability leadership for healthcare products in July

The top healthcare stories this week include how AI can help drug development, NHS's deployment of Microsoft AI and AMD's healthcare AI partnership

British pharmaceuticals company Haleon commits funding to new Madhya Pradesh facility as part of strategy to reach 300 million additional consumers by 2030

GSK is set to acquire oncology therapy specialist Nuvalent for US$10.6bn, adding three lung cancer assets and strengthening its precision medicine pipeline

More News

Featured

ASUS’s integrated platform connects the Handheld Ultrasound DuoScan and VivoWatch 6 Plus to allow frontline medical staff to take instant clinical action

Read more

The strategic collaboration combines clinical data with advanced cloud engineering to improve patient outcomes and support complex medical decision-making

Read more
Featured

KPMG has published a Global Tech Report for Healthcare which reveals evolving trends in the industry, with increased AI use and adoption of new technology

Read more
Featured

The EU has unveiled a roadmap to phase out animal testing in chemical safety assessments, advancing human-relevant science while protecting health

Read more

Snowflake acquires Natoma to help healthcare organisations govern AI agents across fragmented clinical and administrative systems with proper compliance

Read more
Featured

Sanofi's Dr Andrea Michael Meyer explores how supply chain management and cross-industry collaborations can help make the pharma sector more resilient

Read more
Featured

The new £2m (US$2.69m) outdoor facility allows critically ill patients to experience nature and fresh air while remaining connected to life-support systems

Read more
Featured

The top healthcare stories this week include the impact of menopause on the workforce, the impact of precision medicine and women's health in UK strategy

Read more

Encouraging Phase 2 results show a robust immune response against serotype 3, prompting pivotal Phase 3 trials to protect up to 90% of paediatric patients

Read more
Featured

Pfizer secures expanded EU approval for a once-weekly haemophilia treatment, widening care options for patients aged 12 and older across Europe

Read more